Unilabs

At Unilabs, we believe in the power of effective diagnostics and preventative care to support all those in pursuit of a healthier life. This World Mental Health Day is a timely reminder to all of us that maintaining mental wellbeing through regular self-care is just as important as ensuring our physical health.    One of the ways we support the mental wellbeing of people and communities is through our genetic counselling service. By helping individuals to understand their genetic makeup and thus, possible risks, genetic counselling can encourage people to take proactive steps towards a healthier future for themselves and their family. Our service also addresses the emotional impact of genetic conditions, supporting patients as they navigate complex decisions. To find out more about genetic testing, you can read our interview with Marie Met-Domestici, a seasoned genetic counsellor at Unilabs Switzerland: https://lnkd.in/gNqWYD_d   However self-care looks for you, let’s all use World Mental Health Day to recommit to it.   #Healthcare #Patients #HealthTech #MentalHealth #WorldMentalHealthDay

Breast cancer remains one of the most common cancers worldwide, impacting millions of individuals each year. Early detection leads to better outcomes for patients so, this Pink October, we’re sharing 12 expert tips for detecting breast cancer from Dr Hanna Bjerke, a leading specialist in breast radiology at Unilabs Norway.    Here are the first three. For more detail on each of these potential breast cancer symptoms, click on the link below to read Dr Bjerke’s insights in full. If you recognise any of these signs, we recommend a visit to your healthcare provider for a check-up.    https://lnkd.in/d3rSbShn   #Healthcare #Patients #BreastCancer #PinkOctober #Mammography   

Every year, Alzheimer's disease robs millions of people worldwide of their memories, cognitive abilities, and independence. One of the best things we can do for Alzheimer’s patients is to broaden access to faster, cheaper diagnostic solutions that allow us to target the disease in its earliest stages, before irreversible brain damage or mental decline has occurred. Our partnership with C2N, whose innovative portfolio of blood tests can detect Alzheimer’s disease markers is helping us to inform medical management and treatment. With tests becoming available later in the year, we believe this partnership will transform the diagnostic experience for people with cognitive concerns and generate better long-term outcomes. To mark World Alzheimer’s Day, we sat down with Unilabs’ Clinical Pathologist and Head of Medical at Unilabs Switzerland, Dr Dany Mercan, to discuss in detail, the science behind some of today’s diagnostic tools as well as some of the newer techniques we’re exploring to encourage early Alzheimer’s detection in our efforts to power health and maximise life. If you’d like to delve into the technical aspects of diagnosing Alzheimer’s disease, read our interview here. #Healthcare #Patients #HealthTech

How can AI-driven diagnostics save lives? Join us at the Ars Electronica Festival for Art, Technology, and Society in Austria, from 4 September. As an international leader in diagnostic services, this year's theme, “HOPE – Who Will Turn the Tide,” aligns perfectly with Unilabs’ mission to power health and maximise life. We're excited to showcase the ways in which Unilabs is already harnessing AI to revolutionise healthcare; to transform early diagnosis, advance research, and personalise diagnostic services. If you're attending the festival, don't miss our special panel session on ‘STARTS’ day on 5 September. This is a day focused to how we can reclaim, reimagine and regulate our digital landscape. Unilabs’ Head of AI Centre of Excellence, Claudio Silvestrin, will explore AI's future impact and considerations in clinical practice, alongside prominent digital researchers:  - Albert Ortig, founder of Netural GmbH - Apolinário Passos (Poli), Head of Machine Learning for Art and Creativity at Hugging Face - Frederike Kaltheuner, Europe and Global Governance Lead at the AI Now Institute - Thomas Nayer, founder of Dogether For more details, visit: https://lnkd.in/gKmsGDyV #AI #arselectronica24 #arselectronica #Healthcare

Groundbreaking innovations in molecular profiling and targeted therapy are unlocking more precise and personalised approaches to diagnosis and treatment, transforming cancer patients’ fight against the disease.  Our latest technology innovations range from allele-specific PCR, which can detect specific single-nucleotide variants (SNVs) in a patient's DNA, to next-generation sequencing (NGS) and more traditional methods like Sanger sequencing for detecting unknown mutations in genes. These tools allow us to identify known mutations that have implications for treatment decisions, and provide valuable information about single-nucleotide changes.   Combined with targeted therapy, we are able to enhance treatment effectiveness while minimising damage to healthy cells and support a better quality of care and life for cancer patients. We interview with Unilabs’ Dr Jana Verebová on molecular testing and new cancer diagnostic tests here: https://lnkd.in/e4ftsHTY As research advances, we expect more targeted therapies and broader molecular testing, which will further transform cancer treatment and prognosis. #Cancer #Oncology #Healthcare 

AI is revolutionising medical fields like radiology by streamlining diagnostic processes, enhancing productivity, and ultimately improving patient outcomes. We spoke with Dr Stavroula Kyriazi, MD, clinical lead for the emergency radiology section at Unilabs’ AI Centre of Excellence, to explore these developments in-depth, focusing on how healthcare professionals are navigating this new frontier of AI-assisted healthcare. At Unilabs, our AI solutions are enhancing detection of over 100 different conditions, including brain aneurysms, tumours and haemorrhages, with three significant AI radiology solutions looking at CT Intracranial angiograms, covering images with and without contrast. An additional three of our innovative AI applications are frequently used in emergency brain CT scanning. Over 250,000 Unilabs examinations have been AI-assisted to date. Read about the intersection between radiology and AI as well as Dr Kyriazi’s insights in our interview here:  https://lnkd.in/eJMfWRNV #AI #Radiology #Tech #Healthcare

“What I find most enjoyable in my work is the significant variation in daily tasks. We receive a wide range of specimens, and it takes time to gain experience and encounter the different variations, so we often seek advice from colleagues, which also makes the work interesting and challenging.” – Unilabs Biomedical Analyst Katarina Huhmarniemi In the second instalment of our series spotlighting Unilabs pathology technicians from across the world, we spoke to Biomedical Analyst Katarina Huhmarniemi in Sweden about her work and the measures taken to guarantee accuracy and precision in laboratory procedures. Read more here: https://lnkd.in/e_at4rFf  #Pathology #Medicine #Diagnostics #UnilabsCareers

Understanding genetic factors in hereditary cancer helps tailor proactive management and preventive measures, aiming for the best possible patient outcomes and support. Some cancers have a stronger genetic predisposition, with hereditary syndromes making up around 3-20% of all cancer cases. Unilabs provides oncogenetic consultations which can unlock possible risk-reducing interventions and provide informed clinical decisions for the patient. Developments in next-generation sequencing allow us to quickly analyse multiple genes at once, helping identify harmful gene changes linked to hereditary cancers. Additionally, new treatments like PARP inhibitors and checkpoint inhibitors show promise for cancers with specific genetic mutations.  Learn more from Unilabs' Oncogenetics specialist Dr Zuzana Mazerikova.  https://lnkd.in/eN_vp_64 #Genetics #Oncology #Cancer #Healthcare 

Lung cancer is one of the most common and deadliest cancers globally.    Following World Lung Cancer Day, Unilabs highlights the importance of continuing to raise awareness and empowering those affected by this devastating disease. To shed light on the current landscape of lung cancer, we had the opportunity to sit down with Matthew Ginder, Unilabs’ TMC Head of Business Unit UK, who brings a wealth of knowledge and experience in this field.     Matthew gives insights into the critical aspects of lung cancer, emphasising the importance of early detection and the collective efforts needed to combat this illness. Read on to learn more about these topics, along with the groundbreaking research Unilabs is leading on early diagnosis through the UK's national lung health check programme.     #WorldLungCancerDay #Cancer #HealthCare 

In this interview with Dr Carlos Mendes, Clinical Pathology Medical Specialist at Unilabs, we explore the diverse spectrum of blood cancers, including leukaemia and myelodysplastic syndromes, and the significant role of a multi-disciplinary approach combining clinical, laboratory and genomic data to ensure a holistic care approach. He also looks at advancements in the sensitivity and specificity of lab tests which are revolutionising the field. Read the full interview in our blog here: https://lnkd.in/efzdhYN7 #Cancer #BloodCancerAwarenessMonth #HealthCare